Mizuho raises Axsome stock target to $195, maintains Outperform
Securities exhibited confidence in Axsome Therapeutics (NASDAQ:AXSM) by increasing the company's price target from $137.00 to $195.00. The firm has maintained an Outperform rating on the stock. This ...
24/7 Wall St. on MSN42m
Our 4 Favorite Strong Buy Ultra-High-Yield Stocks All Yield 12% and More
Investors love dividend stocks, especially the ultra-high-yield variety, because they offer a significant income stream and ...